Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Defer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
Impairment of circulating lactoferrin in HIV-1 infectionM C Defer, B Dugas, O Picard, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|July 1, 1994
Antilactoferrin autoantibodies associated with HIV infectionM C Defer, J Y Follézou, O Picard, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|November 1, 1994
[Role of interleukin-4 in the regulation of nitric oxide production by normal human monocytes]M C Defer, B Dugas, N Paul-Eugène, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Differential pattern in circulating nitrogen derivatives, lactoferrin, and anti-lactoferrin antibodies in HIV type 1 and HIV type 2 infectionsV Dapsanse, M C Defer, J Y Follézou, et al.
Epidemiology and Infection|June 14, 2013
Are healthcare workers at higher risk of HIV infection than the general population in Burkina Faso?F Kirakoya-Samadoulougou, P Fao, S Yaro, et al.
Sexually Transmitted Infections|April 1, 2004
Review of STI and HIV epidemiological data from 1990 to 2001 in urban Burkina Faso: implications for STI and HIV controlN Nagot, N Meda, A Ouangre, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
One-year follow-up of vaccine therapy in HIV-infected immune-deficient individuals: a new strategyD Zagury, J Bernard, A Halbreich, et al.
Sexually Transmitted Infections|July 4, 2008
Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African womenP Mayaud, N Nagot, I Konaté, et al.
The Journal of Infectious Diseases|July 3, 2008
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levelsN Nagot, A Ouedraogo, I Konate, et al.
Sexually Transmitted Infections|December 7, 2007
Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina FasoN Nagot, A Ouedraogo, H A Weiss, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
Impairment of circulating lactoferrin in HIV-1 infectionM C Defer, B Dugas, O Picard, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|July 1, 1994
Antilactoferrin autoantibodies associated with HIV infectionM C Defer, J Y Follézou, O Picard, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|November 1, 1994
[Role of interleukin-4 in the regulation of nitric oxide production by normal human monocytes]M C Defer, B Dugas, N Paul-Eugène, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Differential pattern in circulating nitrogen derivatives, lactoferrin, and anti-lactoferrin antibodies in HIV type 1 and HIV type 2 infectionsV Dapsanse, M C Defer, J Y Follézou, et al.
Epidemiology and Infection|June 14, 2013
Are healthcare workers at higher risk of HIV infection than the general population in Burkina Faso?F Kirakoya-Samadoulougou, P Fao, S Yaro, et al.
Sexually Transmitted Infections|April 1, 2004
Review of STI and HIV epidemiological data from 1990 to 2001 in urban Burkina Faso: implications for STI and HIV controlN Nagot, N Meda, A Ouangre, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
One-year follow-up of vaccine therapy in HIV-infected immune-deficient individuals: a new strategyD Zagury, J Bernard, A Halbreich, et al.
Sexually Transmitted Infections|July 4, 2008
Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African womenP Mayaud, N Nagot, I Konaté, et al.
The Journal of Infectious Diseases|July 3, 2008
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levelsN Nagot, A Ouedraogo, I Konate, et al.
Sexually Transmitted Infections|December 7, 2007
Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina FasoN Nagot, A Ouedraogo, H A Weiss, et al.
Pageof 1